Bay Rivers Group »

Milestone Pharmaceuticals shares owned by Bay Rivers Group

Quarter-by-quarter ownership of Milestone Pharmaceuticals (MIST) shares owned by Bay Rivers Group from 13F filings

Historical chart of Bay Rivers Group investment in Milestone Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Milestone Pharmaceuticals held by Bay Rivers Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Milestone Pharmaceuticals by Bay Rivers Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $33k 17k 2.00
2025-06-30 $28k 14k 1.94

More positions owned by Bay Rivers Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Broadcom (AVGO)
Ishares Tr Msci Usa Min Vol (USMV)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Meta Platforms Cl A (META)
Vanguard Specialized Funds Div App Etf (VIG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Vaneck Etf Trust Semiconductr Etf (SMH)
Vanguard Index Fds Growth Etf (VUG)
Blackrock Etf Trust Ii Ishares Flexible (BINC)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)

View all positions for Bay Rivers Group

Top funds holding Milestone Pharmaceuticals

Adage Capital Partners GP
Propel Bio Management
OrbiMed Advisors
Simplify Asset Management
Rtw Investments
Pathstone Holdings
Morgan Stanley
Sphera Funds Management
Toronto-Dominion Bank
Affinity Asset Advisors
Boxer Capital Management
Two Sigma Investments
Lion Point Capital
Citadel Advisors
Susquehanna International

View all funds holding Milestone Pharmaceuticals